MLchartDataset catalogue

sapanisertib

Term · Oncology and biomedicine · MLC-T-ONC-016639

An orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. Sapanisertib binds to and inhibits both TORC1 and TORC2 complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. TORC1 and 2 are upregulated in some tumors and play an important role in the PI3K/Akt/mTOR signaling pathway, which is frequently dysregulated in human cancers.

Table 1. Record
IdentifierMLC-T-ONC-016639
FieldOncology and biomedicine
SynonymsTORC1/2 Inhibitor INK128
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016639",
  "term": "sapanisertib",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. Sapanisertib binds to and inhibits both TORC1 and TORC2 complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. TORC1 and 2 are upregulated in some tumors and play an important role in the PI3K/Akt/mTOR signaling pathway, which is frequently dysregulated in human cancers.",
  "synonyms": [
    "TORC1/2 Inhibitor INK128"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/sapanisertib/"
}

Record 14,676 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.